Lisa Gora to Present at 2020 Asia Hemp Investment Summit in Hong Kong

Tuesday, January 14, 2020

Kerry Hotel in Victoria Harbor, Wan Chai Pier, Hong Kong

Lisa Gora, Wilentz corporate and cannabis law attorney, will present “Status of Cannabis in the United States from a Federal and State Perspective” at the 2020 Asia Hemp Investment Summit. Ms. Gora will discuss the conflict between federal and state laws in the United States regarding cannabis, the concept of federal preemption, the 2018 Farm Bill and its effects on hemp and hemp derivatives (including CBD), and the rules and regulations surrounding importing cannabis products to the United States.

Hosted by CBDG Hemp Industry Fund, the Summit will provide a platform for funds, development institutions, branding companies and others interested in entering the legal cannabis market to exchange investment and financing ideas and review hemp projects from all over the world.

At Wilentz, Ms. Gora focuses her cannabis law practice on the representation of alternative treatment centers, medical marijuana dispensaries, caregivers, physicians, and hospitals with respect to issues related to recommending, authorizing, administering and possessing medical cannabis pursuant to New Jersey law, rules, regulations and policies. She also serves as NJSBA Cannabis Law Committee Secretary.

*Cannabis Law Disclaimer: Per federal law, under the Controlled Substances Act, marijuana is categorized as a Schedule I controlled substance.  Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy, regardless of any state law that may authorize certain marijuana activity.  Compliance with state marijuana law does not equal compliance with federal law.  Legal advice provided by Wilentz, Goldman & Spitzer, P.A. is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Wilentz, Goldman & Spitzer, P.A. will not provide guidance or assistance in circumventing or violating Federal or state cannabis law or policy, and any advice provided by Wilentz, Goldman & Spitzer, P.A. should not be construed as such.